Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AlloEx
- Development stage
- Phase 1
- Lead developer
- Vitro Biopharma
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cell Therapies
- Administration
- Intranasal
01
Overview
AlloEx is a therapeutic candidate consisting of exosomes derived from cultured allogeneic adult umbilical cord mesenchymal stem cells (UC-MSCs). As extracellular vesicles, these exosomes carry a complex cargo of proteins, lipids, and RNA species that mediate paracrine signaling to promote tissue regeneration, immunomodulation, and neuroprotection. The product is primarily administered via intranasal instillation, a route designed to facilitate the delivery of bioactive molecules across the blood-brain barrier to the central nervous system. AlloEx is being investigated in multiple clinical trials for various neurological and motor disorders, including Parkinson's disease, stroke, amyotrophic lateral sclerosis (ALS), and trigeminal neuralgia, aiming to attenuate disease progression and improve functional outcomes.
- Brand names
- AlloExAlloEx Exosome
- Other names
- Allogeneic umbilical cord-derived mesenchymal stem cell exosomesUC-MSC exosomesCultured allogeneic adult umbilical cord derived mesenchymal stem cell exosomes
Beyond the preview
Go deeper on AlloEx.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AlloEx.